Suppr超能文献

促甲状腺激素敏感放射免疫测定法的研制及其临床应用(作者译)

[The development of a sensitive radioimmunoassay for H-TSH and its clinical application (author's transl)].

作者信息

Mori T, Tamaki N, Ishihara T, Bito S, Ito H, Morimoto Y, Oshiro N

出版信息

Nihon Naibunpi Gakkai Zasshi. 1980 Sep 20;56(9):1231-9. doi: 10.1507/endocrine1927.56.9_1231.

Abstract

Using a commercially available h-TSH RIA kit (Daiichi), a sensitive RIA method was developed. When pooled serum from patients with active Graves' disease was used as a carrier, combined applications of a delayed addition of 125-I TSH and utilization of X2 diluted anti-TSH antibody resulted in the consistent detection of 0.156 microunits/ml level of serum TSH. Further, 0.078 microunits/ml level could also be detected when 200 microliter of serum samples were applied. However, usage of 200 microliter sample volume should be determined after further studies concerning possible non specific effects of human serum. Assay results of 29 patient sera by the sensitive assay correlated quite well (r = 0.953, Y = 0.97X-0.06) with those by the regular assay. Serum TSH in all of the 20 normal subjects were detectable and ranged from 0.31 to 3.2 microunits/ml giving mean values of 1.48 +/- 0.65 (s.d.) microunits/ml. Values less than 0.156 microunits/ml were observed in patients with untreated Graves' disease, acute stage of subacute thyroiditis, and panhypopituitarism, and in postoperative cancer patients under suppressive doses of T-4. In conclusion, this sensitive TSH RIA made clear discrimination of low and normal serum TSH possible, and the clinical application of this method was considered quite useful.

摘要

使用市售的人促甲状腺激素放射免疫分析试剂盒(第一制药),开发了一种灵敏的放射免疫分析方法。当将来自活动性格雷夫斯病患者的混合血清用作载体时,采用延迟添加125-I促甲状腺激素以及使用X2稀释的抗促甲状腺激素抗体的联合应用,能够一致地检测出血清促甲状腺激素水平为0.156微单位/毫升。此外,当应用200微升血清样本时,还能检测到0.078微单位/毫升的水平。然而,在对人血清可能的非特异性效应进行进一步研究之后,才能确定是否使用200微升的样本体积。通过这种灵敏检测法对29例患者血清的检测结果与常规检测法的结果相关性非常好(r = 0.953,Y = 0.97X - 0.06)。20名正常受试者的血清促甲状腺激素均可检测到,范围为0.31至3.2微单位/毫升,平均值为1.48±0.65(标准差)微单位/毫升。在未治疗的格雷夫斯病患者、亚急性甲状腺炎急性期患者、全垂体功能减退患者以及接受抑制剂量T-4治疗的术后癌症患者中,观察到促甲状腺激素值低于0.156微单位/毫升。总之,这种灵敏的促甲状腺激素放射免疫分析能够清晰地区分血清促甲状腺激素的低水平和正常水平,该方法的临床应用被认为非常有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验